Anterix (NASDAQ:ATEX) had its price target upped by investment analysts at Craig Hallum from $80.00 to $100.00 in a research note issued on Monday, The Fly reports. The brokerage presently has a “buy” rating on the stock. Craig Hallum’s price target would indicate a potential upside of 120.56% from the stock’s current price.
ATEX has been the subject of a number of other research reports. BidaskClub cut shares of Anterix from a “sell” rating to a “strong sell” rating in a research note on Saturday. Zacks Investment Research cut Anterix from a “hold” rating to a “sell” rating in a research note on Tuesday, June 23rd. Finally, B. Riley raised their price target on Anterix from $59.00 to $75.00 and gave the stock a “buy” rating in a research report on Friday, May 22nd. Two research analysts have rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the company’s stock. Anterix presently has an average rating of “Hold” and an average price target of $68.17.
NASDAQ ATEX opened at $45.34 on Monday. The company has a quick ratio of 16.11, a current ratio of 16.11 and a debt-to-equity ratio of 0.03. The stock’s 50-day simple moving average is $53.15 and its two-hundred day simple moving average is $47.46. Anterix has a twelve month low of $29.38 and a twelve month high of $57.75. The company has a market capitalization of $777.92 million, a price-to-earnings ratio of -20.06 and a beta of 0.36.
Anterix (NASDAQ:ATEX) last announced its quarterly earnings data on Thursday, May 28th. The company reported ($0.68) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.52) by ($0.16). Anterix had a negative net margin of 2,406.52% and a negative return on equity of 16.06%. On average, equities analysts expect that Anterix will post -2.16 earnings per share for the current fiscal year.
In other Anterix news, major shareholder Owl Creek Asset Management, L. acquired 200,000 shares of the company’s stock in a transaction on Wednesday, May 13th. The stock was acquired at an average price of $54.08 per share, for a total transaction of $10,816,000.00. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Timothy Gray sold 2,094 shares of Anterix stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $58.18, for a total value of $121,828.92. Following the completion of the sale, the chief financial officer now owns 57,957 shares in the company, valued at $3,371,938.26. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 12,876 shares of company stock valued at $697,544. Insiders own 6.74% of the company’s stock.
Institutional investors have recently made changes to their positions in the stock. Great West Life Assurance Co. Can bought a new stake in shares of Anterix during the fourth quarter valued at approximately $36,000. Bank of Montreal Can boosted its stake in Anterix by 30.1% during the 4th quarter. Bank of Montreal Can now owns 1,881 shares of the company’s stock valued at $81,000 after purchasing an additional 435 shares during the last quarter. Citigroup Inc. increased its holdings in shares of Anterix by 94.4% in the 4th quarter. Citigroup Inc. now owns 2,578 shares of the company’s stock worth $111,000 after purchasing an additional 1,252 shares in the last quarter. IndexIQ Advisors LLC purchased a new position in shares of Anterix in the first quarter worth $196,000. Finally, Aperio Group LLC bought a new position in shares of Anterix during the first quarter valued at $212,000.
Anterix Inc operates as a wireless communications company. The company focuses on enabling private broadband connectivity for critical infrastructure and enterprise businesses. It holds licensed spectrum in the 900 MHz band with nationwide coverage throughout the United States, Hawaii, Alaska, and Puerto Rico.
Featured Article: Retained Earnings
Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.